Influence of trastuzumab on the incidence of brain metastasis in patients with Her2-overexpressing metastatic breast cancer

被引：0
|
作者：
Massard, C.
Brain, E.
Dunan, A.
Mathieu, M.
Guinebretiere, J.
Abuin, G. Gomez
Floiras, J.
Spielmann, M.
Delaloge, S.
Andre, F.
机构：
[1] Inst Gustave Roussy, Breast Canc Unit, Villejuif, France
[2] Ctr Rene Huguenin, Dept Med, St Cloud, France
[3] Inst Gustave Roussy, Dept Stat, F-94805 Villejuif, France
[4] Inst Gustave Roussy, Dept Pathol, Villejuif, France
[5] Ctr Rene Huguenin, Dept Pathol, St Cloud, France
[6] Ctr Rene Huguenin, Dept Radiat Therapy, St Cloud, France
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：119 / 120
页数：2
相关论文
共 50 条
  • [1] High incidence of brain metastases in HER2-overexpressing metastatic breast cancer (MBC) patients (pts) treated with trastuzumab and chemotherapy
    Gori, S.
    Rimondini, S.
    De Angelis, V.
    Sidoni, A.
    Mosconi, A. M.
    Aristei, C.
    Franceschi, E.
    Esposti, R. Degli
    Colozza, M.
    Crino, L.
    EJC SUPPLEMENTS, 2005, 3 (02): : 115 - 116
  • [2] Weekly Gemcitabine and Trastuzumab in the Treatment of Patients With HER2-Overexpressing Metastatic Breast Cancer
    Yardley, Denise A.
    Burris, Howard A., III
    Hanson, Sarah
    Greco, F. Anthony
    Spigel, David R.
    Barton, John
    Hainsworth, John D.
    CLINICAL BREAST CANCER, 2009, 9 (03) : 178 - 183
  • [3] Tolerability and activity of trastuzumab in elderly patients with HER2-overexpressing metastatic breast cancer
    Zucchini, G.
    Bernardi, A.
    Martoni, A.
    Zamagni, C.
    ANNALS OF ONCOLOGY, 2013, 24 (01) : 264 - 265
  • [4] Incidence of brain metastasis (BM) in HER-2 overexpressing metastatic breast cancer (MBC) responsive to trastuzumab
    Stemmler, J
    Kahlert, S
    Siekiera, W
    Heinrich, B
    Untch, M
    Heinemann, V
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S130 - S130
  • [5] Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer
    Makiko Ono
    Masashi Ando
    Mayu Yunokawa
    Eriko Nakano
    Kan Yonemori
    Koji Matsumoto
    Tsutomu Kouno
    Chikako Shimizu
    Kenji Tamura
    Noriyuki Katsumata
    Yasuhiro Fujiwara
    International Journal of Clinical Oncology, 2009, 14 : 48 - 52
  • [6] Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer
    Ono, Makiko
    Ando, Masashi
    Yunokawa, Mayu
    Nakano, Eriko
    Yonemori, Kan
    Matsumoto, Koji
    Kouno, Tsutomu
    Shimizu, Chikako
    Tamura, Kenji
    Katsumata, Noriyuki
    Fujiwara, Yasuhiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (01) : 48 - 52
  • [7] Brain metastases in HER2-overexpressing metastatic breast cancer (MBC) patients (PTS)
    Gori, S.
    Rimondini, S.
    De Angelis, V.
    Sidoni, A.
    Mosconi, A. M.
    Aristei, C.
    Perrucci, E.
    Basurto, C.
    Franceschi, E.
    Scopece, L.
    Degli Esposti, R.
    Colozza, M.
    Crino, L.
    ANNALS OF ONCOLOGY, 2005, 16 : 10 - 11
  • [8] Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer
    Burstein, HJ
    Kuter, I
    Campos, SM
    Gelman, RS
    Tribou, L
    Parker, LM
    Manola, J
    Younger, J
    Matulonis, U
    Bunnell, CA
    Partridge, AH
    Richardson, PG
    Clarke, K
    Shulman, LN
    Winer, EP
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (10) : 2722 - 2730
  • [9] Effects of trastuzumab and paclitaxel in HER2-overexpressing breast cancer
    Li, Songhua
    Higuchi, Hideo
    Ohuchi, Noriaki
    FUTURE MEDICAL ENGINEERING BASED ON BIONANOTECHNOLOGY, PROCEEDINGS, 2006, : 395 - +
  • [10] Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer
    Datko, F.
    D'Andrea, G.
    Dickler, M.
    Theodoulou, M.
    Goldfarb, S.
    Lake, D.
    Fornier, M.
    Modi, S.
    Sklarin, N.
    Comen, E.
    Fasano, J.
    Gajria, D.
    Drullinsky, P.
    Gilewski, T.
    Murphy, C.
    Syldor, A.
    Lau, A.
    Hamilton, N.
    Patil, S.
    Liu, J.
    Chandarlapaty, S.
    Hudis, C.
    Dang, C.
    CANCER RESEARCH, 2012, 72
12345